Brief: Prophase Labs Announces Plans To Initiate Clinical Trial Of Equivir

Prophase Labs

22/02/2023 13:23

Feb 22 (Reuters) - Prophase Labs Inc  PRPH.O :
    * PROPHASE LABS ANNOUNCES PLANS TO INITIATE CLINICAL TRIAL
OF
EQUIVIR 
    * COMPANY EXPECTS TRIAL COMPLETION IN Q3 OF 2023
    * SEEK TO LAUNCH EQUIVIR AS AN OVER-THE-COUNTER DIETARY
SUPPLEMENT
IN Q4 OF 2023

Source text for Eikon:  ID:nGNX89FJPh 
Further company coverage:  PRPH.O